Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health.
Join us at SynergyLabs® in our pursuit of innovation! As a concept-to-shelf American manufacturer, we produce over 150 branded and private-label products sold in pet specialty, veterinary, grocery, mass merchandisers, and big-box stores across 65 countries worldwide. Our chemistry and research and development experts lead the way in scientific and innovative products for dogs and cats, including nutritional supplements, grooming, health, and veterinary items.
For 6 consecutive years, Inc 5000 has recognized SynergyLabs as one of America's Fastest-Growing Privately Held Companies. Our dedication to growing healthy, active, and happy pets (and their parents!) is at the heart of everything we do. Join us in our mission to innovate and improve the lives of pets worldwide.
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Employing a proprietary Fast-Clear linker technology, Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion's lead program, FPI-1434, is currently in a Phase 1 clinical trial.
Fusion is headquartered in Hamilton, ON, with offices in Boston, MA.